GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Corvus Pharmaceuticals Inc (FRA:C17) » Definitions » All Taxes Paid

Corvus Pharmaceuticals (FRA:C17) All Taxes Paid


View and export this data going back to 2016. Start your Free Trial

What is Corvus Pharmaceuticals All Taxes Paid?

All Taxes Paid only applicable to companies reporting Cash Flow from Operations in direct method.


Corvus Pharmaceuticals Business Description

Comparable Companies
Traded in Other Exchanges
Address
863 Mitten Road, Suite 102, Burlingame, CA, USA, 94010
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical engaged in developing drugs and antibodies that target the critical cellular elements of the immune system. It focuses on the development of immune modulator product candidates to treat COVID-19, T-cell lymphomas, other cancers, and autoimmune diseases. The company's primary product candidate is Soquelitinib (CPI-818), an oral, small-molecule drug that selectively inhibits ITK (interleukin-2-inducible T cell kinase). The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).